Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
31.57
-0.04 (-0.11%)
Jun 10, 2026, 12:34 PM EDT - Market open
Pharvaris Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 246.96 | 291.68 | 280.73 | 391.23 | 161.84 | 209.35 |
Cash & Short-Term Investments | 246.96 | 291.68 | 280.73 | 391.23 | 161.84 | 209.35 |
Cash Growth | 4.42% | 3.90% | -28.24% | 141.74% | -22.70% | 112.26% |
Accounts Receivable | 0.97 | 0.56 | 0.46 | 0.42 | 0.38 | 0.7 |
Other Receivables | 4.01 | 3.99 | 2.49 | 0.62 | - | - |
Total Trade Receivables | 4.98 | 4.55 | 2.94 | 1.04 | 0.38 | 0.7 |
Other Current Assets | 5.75 | 2.94 | 5.75 | 5.58 | 4.63 | 1.51 |
Total Current Assets | 257.68 | 299.17 | 289.42 | 397.85 | 166.85 | 211.57 |
Net Property, Plant & Equipment | 1.36 | 1.4 | 1.48 | 0.46 | 0.63 | 0.35 |
Other Long-Term Assets | 0.75 | 0.89 | 0.47 | 0.39 | 0.26 | 0.17 |
Total Assets | 259.79 | 301.46 | 291.38 | 398.69 | 167.73 | 212.09 |
Accounts Payable | 2.71 | 5.11 | 4.56 | 2.91 | 6.69 | 2.49 |
Accrued Expenses | 19.05 | 23.35 | 17.59 | 11.07 | 10.89 | 4.27 |
Current Portion of Leases | 0.21 | 0.2 | 0.22 | 0.2 | 0.19 | 0.1 |
Other Current Liabilities | 0.96 | 0.94 | 0.6 | 0.43 | 0.46 | 0.13 |
Total Current Liabilities | 22.92 | 29.6 | 22.98 | 14.6 | 18.22 | 6.99 |
Long-Term Leases | 0.53 | 0.58 | 0.64 | 0.04 | 0.25 | 0.15 |
Total Long-Term Liabilities | 0.53 | 0.58 | 0.64 | 0.04 | 0.25 | 0.15 |
Total Liabilities | 23.46 | 30.18 | 23.61 | 14.65 | 18.47 | 7.14 |
Common Stock | 7.85 | 7.83 | 6.53 | 6.27 | 4.06 | 3.98 |
Additional Paid-in Capital | 795.29 | 792.55 | 623.64 | 615.81 | 289.18 | 278.74 |
Accumulated Other Comprehensive Income | 52.73 | 50.5 | 39.85 | 27.88 | 20.21 | 9.8 |
Retained Earnings | -619.54 | -579.6 | -402.26 | -265.92 | -164.19 | -87.57 |
Shareholders' Equity | 236.33 | 271.27 | 267.76 | 384.05 | 149.26 | 204.95 |
Total Liabilities & Equity | 259.79 | 301.46 | 291.38 | 398.69 | 167.73 | 212.09 |
Total Debt | 0.74 | 0.78 | 0.86 | 0.24 | 0.44 | 0.25 |
Net Cash (Debt) | 246.22 | 290.9 | 279.87 | 390.99 | 161.4 | 209.1 |
Net Cash Growth | -15.36% | 3.94% | -28.42% | 142.25% | -22.81% | 112.01% |
Net Cash Per Share | 3.98 | 4.92 | 5.18 | 10.18 | 4.81 | 6.88 |
Book Value | 236.33 | 271.27 | 267.76 | 384.05 | 149.26 | 204.95 |
Book Value Per Share | 3.82 | 4.59 | 4.96 | 10.00 | 4.44 | 6.74 |
Tangible Book Value | 236.33 | 271.27 | 267.76 | 384.05 | 149.26 | 204.95 |
Tangible Book Value Per Share | 3.82 | 4.59 | 4.96 | 10.00 | 4.44 | 6.74 |